ro 31-8220 and sl0101
ro 31-8220 has been researched along with sl0101 in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
| Huang, J; Li, H; Liu, X; Xu, Y; Xue, M; Yuan, J; Zhao, X; Zhao, Z; Zhong, Y | 1 |
| Gussio, R; Hecht, SM; Lannigan, DA; Nguyen, TL; Scudiero, DA; Shoemaker, RH; Smith, JA; Zaharevitz, DW | 1 |
Other Studies
3 other study(ies) available for ro 31-8220 and sl0101
| Article | Year |
|---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |
Substituted indolin-2-ones as p90 ribosomal S6 protein kinase 2 (RSK2) inhibitors: Molecular docking simulation and structure-activity relationship analysis.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Indoles; Male; Molecular Docking Simulation; Prostatic Neoplasms; Protein Kinase Inhibitors; Ribosomal Protein S6 Kinases, 90-kDa; Structure-Activity Relationship | 2013 |
Homology model of RSK2 N-terminal kinase domain, structure-based identification of novel RSK2 inhibitors, and preliminary common pharmacophore.
Topics: Benzopyrans; Binding Sites; Indoles; Kaempferols; Models, Molecular; Monosaccharides; Naphthalenes; Protein Conformation; Protein Structure, Tertiary; Pyrimidines; Ribosomal Protein S6 Kinases, 90-kDa; Structure-Activity Relationship | 2006 |